Medidata Solutions is the world's most widely used clinical trial technology platform, powering more clinical research studies than any other provider across the pharmaceutical, biotechnology, and medical device industries.
Founded in 1999 and headquartered in New York, Medidata built its reputation on Rave EDC, an electronic data capture system that became the industry standard for collecting and managing clinical trial data. Over the decades the company expanded its offering into a unified cloud platform, the Medidata Clinical Cloud, which connects sponsors, contract research organisations, sites, and patients across the full trial lifecycle. The platform covers data management, randomisation and trial supply management, risk-based monitoring, safety reporting, and patient engagement tools, all operating within a validated, regulatory-compliant environment.
In 2019 Medidata was acquired by Dassault Systemes, the French industrial software group, giving the business additional engineering depth and global distribution. Today Medidata's Acorn AI division applies machine learning and real-world data analytics to trial design, site selection, patient recruitment, and operational benchmarking. The company's proprietary dataset, drawn from thousands of completed studies and millions of trial participants, is among the largest clinical research databases in the world and underpins predictive tools used by sponsors to reduce trial timelines and costs.
Medidata serves customers across oncology, rare diseases, central nervous system disorders, immunology, cardiovascular medicine, and numerous other therapy areas. Its technology is used in trials run by most of the world's top-twenty pharmaceutical companies as well as hundreds of smaller biotechs and CROs. The company also offers the Medidata Rave Patient Cloud and eConsent capabilities, supporting decentralised and hybrid trial designs that have become increasingly prevalent across the industry.
With offices across North America, Europe, and Asia-Pacific, Medidata operates as a truly global clinical technology business embedded at the centre of modern drug development. Further information is available at medidata.com.